Ocata Therapeutics Inc (NASDAQ:OCAT)

5.09
Delayed Data
As of Jul 02
 -0.17 / -3.23%
Today’s Change
4.88
Today|||52-Week Range
12.73
-16.42%
Year-to-Date
No recent news for Ocata Therapeutics Inc.

Today’s Trading

Previous close5.26
Today’s open5.26
Day’s range5.05 - 5.27
Volume252,379
Average volume (3 months)353,829
Market cap$213.6M
Dividend yield--
Data as of 07/02/2015

Growth & Valuation

Earnings growth (last year)-17.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-29.83%
P/E ratioNM
Price/Sales1,206.25
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EGLTEgalet Corp+0.32+2.64%
STMLStemline Therapeutic...-0.18-1.52%
GTXIGTX Inc+0.06+3.97%
ECYTEndocyte Inc0.000.00%
Data as of 07/02/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$157.9K
Annual profit (last year)-$34.7M
Net profit margin-22,010.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul K. Wotton
Chief Operating &
Financial Officer
Edward H. Myles
Corporate headquarters
Marlborough, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers